Tag Archives: Drug

Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis

(Reuters) – A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG, which is seeking to launch a copycat version. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file… Read More »

Senate advances drug pricing bill, setting up September vote

Dive Brief: Legislation limiting drug price increases in Medicare will face a full Senate debate in September after the Finance Committee approved it on a mixed vote Thursday. The bill could see some modification before then to incorporate additional proposals, potentially including a ban on rebates to payers. In addition, House Democrats are working on… Read More »

Relatively Unknown Secret Committees Have Been Influencing Insurers’ Drug Coverage Decisions For Decades

News outlets report on stories related to pharmaceutical pricing. Reuters: The Obscure Advisory Committees At The Heart Of The U.S. Drug Pricing Debate Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries. Priced around $ 7,000 each, the drugmakers called… Read More »

Mulvaney: Trump Brought Down Drug Prices For The First Time In 50 Years

“Drug prices in this country actually came down last year for the first time in 50 years. That’s because Donald Trump’s president.” Mick Mulvaney, April 7, 2019, on “Fox News Sunday” President Donald Trump announced last month that the GOP will become “the party of health care,” and news reports suggest he intends to make… Read More »